Health2Sync goes public as Asia’s diabetes tech leader
Health2Sync, Asia’s largest chronic disease management platform, is going public on Taiwan’s Emerging Stock Board. The digital therapeutics company has 1.6 million users and major backing from electronics giants Wistron and Pegatron.